Join
Live feed
·
PRReleasevia Quantisnow
Abbott Laboratories logo

Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke

ByQuantisnow·Wall Street's wire, on your screen.
ABT· Abbott Laboratories
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABT (Abbott Laboratories) and more on Quantisnow.